On Friday, FibroBiologics Inc (NASDAQ: FBLG) was 13.00% up from the session before settling in for the closing price of $0.35. A 52-week range for FBLG has been $0.24 – $2.54.
When this article was written, the company’s average yearly earnings per share was at -42.16%. With a float of $59.53 million, this company’s outstanding shares have now reached $69.86 million.
FibroBiologics Inc (FBLG) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward FibroBiologics Inc stocks. The insider ownership of FibroBiologics Inc is 24.66%, while institutional ownership is 7.72%. The most recent insider transaction that took place on Dec 11 ’25, was worth 47,600. In this transaction General Counsel of this company bought 140,000 shares at a rate of $0.34, taking the stock ownership to the 140,000 shares. Before that another transaction happened on May 27 ’25, when Company’s Chief Scientific Officer bought 20,000 for $0.84, making the entire transaction worth $16,800. This insider now owns 31,250 shares in total.
FibroBiologics Inc (FBLG) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.09 earnings per share (EPS) during the time that was less than consensus figure (set at -0.07) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -42.16% per share during the next fiscal year.
FibroBiologics Inc (NASDAQ: FBLG) Trading Performance Indicators
You can see what FibroBiologics Inc (FBLG) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.48, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.39 in one year’s time.
Technical Analysis of FibroBiologics Inc (FBLG)
Looking closely at FibroBiologics Inc (NASDAQ: FBLG), its last 5-days average volume was 1.61 million, which is a jump from its year-to-date volume of 0.59 million. As of the previous 9 days, the stock’s Stochastic %D was 86.69%.
During the past 100 days, FibroBiologics Inc’s (FBLG) raw stochastic average was set at 31.87%, which indicates a significant decrease from 90.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0329 in the past 14 days, which was lower than the 0.0396 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3693, while its 200-day Moving Average is $0.6873. However, in the short run, FibroBiologics Inc’s stock first resistance to watch stands at $0.4146. Second resistance stands at $0.4363. The third major resistance level sits at $0.4636. If the price goes on to break the first support level at $0.3656, it is likely to go to the next support level at $0.3383. Now, if the price goes above the second support level, the third support stands at $0.3166.
FibroBiologics Inc (NASDAQ: FBLG) Key Stats
There are 53,275K outstanding shares of the company, which has a market capitalization of 27.45 million. As of now, sales total 0 K while income totals -11,160 K. Its latest quarter income was 0 K while its last quarter net income were -5,780 K.
